All Pharma News
price-trendAsk Us
Changzhou`s Generic Captopril Receives Approval in the U.S.

Changzhou`s Generic Captopril Receives Approval in the U.S.
FDA
27 Jan 2023
Share Share
Changzhou`s Generic Ticagrelor Receives Approval in the U.S.

Changzhou`s Generic Ticagrelor Receives Approval in the U.S.
FDA
12 Dec 2022
Share Share
Ruxolitinib significantly reduces disease and improves quality of life

Ruxolitinib significantly reduces disease and improves quality of life
PRESS RELEASE
29 Mar 2022
Share Share
Heart disease needs a new drug – Vericiguat

Heart disease needs a new drug – Vericiguat
PRESS RELEASE
09 Feb 2022
Share Share
Targeted drug for the treatment of myelofibrosis: Ruxolitinib

Targeted drug for the treatment of myelofibrosis: Ruxolitinib
PRESS RELEASE
11 Jan 2022
Share Share
What are the precautions for rivaroxaban tablets?

What are the precautions for rivaroxaban tablets?
PRESS RELEASE
27 Oct 2021
Share Share
Recent developments of Sugammadex Sodium in the wake period of anesthesia

Recent developments of Sugammadex Sodium in the wake period of anesthesia
PRESS RELEASE
27 Sep 2021
Share Share
Changzhou Pharmaceutical received approval to produce Lenalidomide Capsules

Changzhou Pharmaceutical received approval to produce Lenalidomide Capsules
PRESS RELEASE
11 Sep 2021
Share Share
Guangzhou API exhibition in 2021

Guangzhou API exhibition in 2021
PRESS RELEASE
13 May 2021
Share Share
Changzhou Pharma Doxycycline Hyclate Receives Approval In The US

Changzhou Pharma Doxycycline Hyclate Receives Approval In The US
FDA
11 Oct 2019
Share Share